Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

Georgejjl,

I agree with your statement(in response to RG) that "News could be released any day!!! The anticipation is increasing each and every day!!! ", mainly based on the last two sentences of paragraph 4 of their 1/16/18 pr: “Datasets now in hand, reflecting three successfully completed Phase 2 studies across which multiple endpoints were met, have brought the Company to an important inflection point regarding Brilacidin. In coming weeks, we look forward to advancing these discussions with attractive partnership / licensing scenarios, towards determining the best path forward for the Company and its loyal shareholders.”

This Monday (2/6/18) will complete week seven since that 1/16/18 pr. Perhaps ""coming weeks" should have re-phrased as "coming weeks, month, or possibly more", as come 3/16/18 the time frame becomes months. I believe their studies have generated more interest since SF(see 1/16/18 pr) as reflected in their 1/29/pr where they note, in part " The Confidential Disclosure Agreement (CDA) count toward partnering with global and specialty pharmaceutical companies interested in the Company’s first-in-class drug candidates is nearing 20, with additional Agreements in review."

http://www.ipharminc.com/press-release/2018/1/16/innovation-pharmaceuticals-presents-at-2018-biotech-conference-oral-mucositis-drug-candidate-garners-exceptional-interest-after-successful-phase-2-trial

http://www.ipharminc.com/press-release/2018/1/29/innovation-pharmaceuticals-brilacidin-franchise-anchored-in-three-clinical-indications-oral-mucositis-inflammatory-bowel-disease-and-serious-skin-infections-expands-into-dermatologic-diseases